Jigarning zaharli moddalarni zararsizlantirishdagi biokimyoviy mexanizmlari

Authors
  • Oʻrozboyeva Mashhura Alisherovna

    Tibbiy pedagogika va davolash fakulteti 205-DI guruh talabasi Toshkent davlat tibbiyot universiteti

    Author

Keywords:
jigar, detoksikatsiya, biotransformatsiya, sitoxrom P450, gepatotsit, fermentlar, toksik moddalar, metabolizm, antioksidant tizim, zararsizlantirish jarayoni.
Abstract

 Ushbu maqolada jigarning organizmdagi zaharli moddalarni zararsizlantirishdagi biokimyoviy mexanizmlari yoritilgan. Jigarning detoksikatsion funksiyasi, sitoxrom P450 ferment tizimi, biotransformatsiyaning I va II fazalari hamda antioksidant himoya tizimining ahamiyati tahlil qilingan. Shuningdek, toksik moddalar metabolizmi, ularning gepatotsitlarda parchalanishi va organizmdan chiqarilish jarayonlari haqida ma’lumot berilgan. Jigarning metabolik faoliyati va inson salomatligini saqlashdagi o‘rni ilmiy asosda bayon etilgan.

References

F. P. Guengerich, “Cytochrome P450 research and the future of drug metabolism,” Journal of Biological Chemistry, vol. 295, no. 48, pp. 16315–16334, 2020.

[2] Y. Zhang, J. Ren, and X. Chen, “Role of oxidative stress in liver detoxification and disease progression,” International Journal of Molecular Sciences, vol. 21, no. 21, pp. 1–18, 2020.

[3] A. J. Knights, D. J. Miners, and D. A. Birkett, “Influence of cytochrome P450 polymorphisms on drug metabolism and toxicity,” Clinical Pharmacology & Therapeutics, vol. 109, no. 6, pp. 1509–1524, 2021.

[4] M. C. Lu, H. Y. Ji, and L. Y. Li, “Glutathione homeostasis and its role in liver metabolism and detoxification,” Redox Biology, vol. 41, pp. 101–112, 2021.

[5] S. K. Ramaiah and J. A. Jaeschke, “Hepatic detoxification mechanisms and liver injury: Current perspectives,” Toxicology and Applied Pharmacology, vol. 426, 115–130, 2021.

[6] L. Wang, Q. Wu, and H. Li, “Phase I and Phase II metabolic enzymes in liver detoxification: Recent advances,” Frontiers in Pharmacology, vol. 13, 2022.

[7] N. J. Chalasani et al., “The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance,” Hepatology, vol. 77, no. 3, pp. 1020–1045, 2023.

[8] J. D. Hayes and A. T. Dinkova-Kostova, “The Nrf2 regulatory network provides an interface between redox and intermediary metabolism,” Trends in Biochemical Sciences, vol. 48, no. 2, pp. 120–140, 2023.

[9] K. S. Lee and H. J. Kim, “Role of antioxidant systems in hepatic detoxification processes,” Antioxidants, vol. 12, no. 4, 2023.

[10] R. Gupta and P. Sharma, “Liver detoxification pathways and pharmacological implications,” Biomedicine & Pharmacotherapy, vol. 168, 2024.

[11] J. R. Idle, “Cytochrome P450 enzymes and drug metabolism,” Toxicology Letters, vol. 192, no. 1, pp. 1–6, 2010.

[12] L. L. Brunton, R. Hilal-Dandan, and B. C. Knollmann, Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 13th ed. New York, USA: McGraw-Hill Education, 2018.

[13] J. M. Berg, J. L. Tymoczko, G. J. Gatto, and L. Stryer, Biochemistry, 9th ed. New York, USA: W. H. Freeman and Company, 2019.

[14] D. L. Nelson and M. M. Cox, Lehninger Principles of Biochemistry, 8th ed. New York, USA: W. H. Freeman, 2021.

[15] T. M. Devlin, Textbook of Biochemistry with Clinical Correlations, 8th ed. Hoboken, NJ, USA: Wiley-Liss, 2017.

[16] V. Marks and D. Smith, Basic Medical Biochemistry: A Clinical Approach, 2nd ed. Oxford, UK: Blackwell Science, 2016.

[17] P. C. Turner, A. G. McLennan, A. D. Bates, and M. R. H. White, Instant Notes in Biochemistry, 4th ed. New York, USA: Garland Science, 2018.

Cover Image
Downloads
Published
2026-05-12
Section
Articles

How to Cite

Jigarning zaharli moddalarni zararsizlantirishdagi biokimyoviy mexanizmlari. (2026). Ilm -Fan Taraqqiyoti Respublika Ilmiy Konferensiyasi, 2(2), 146-150. https://doi.org/10.5281/zenodo.20129890

Similar Articles

1-10 of 83

You may also start an advanced similarity search for this article.